Home Compare CVS vs ELV
Stock Comparison · Industry comparison · Healthcare Plans

CVS Health vs Elevance Health: Which Stock Looks Stronger in 2026?

Elevance Health holds the cleaner structural position, with the lead spread across valuation and profitability. CVS Health still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward CVS Health, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Elevance Health, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across valuation and profitability, rather than sitting in one isolated gap. The overall score gap is 21 points in favour of Elevance Health, Inc..

INDUSTRY COMPARISON

Both operate in: Healthcare Plans

This comparison is based on industry proximity, not on functional trajectory similarity. CVS and ELV share the same industry classification.

For a similarity-based comparison, see how CVS Health and Elevance Health each position within their functional peer groups in AssetNext.

Peer-Relative Score
CVS
CVS Health Corporation
40
Peer-Score
Signal qualityMedium
vs
ELV
Elevance Health, Inc.
61
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: CVS vs ELV Profitability 31 64 Stability 39 32 Valuation 35 85 Growth 60 48 CVS ELV
Gap Ranking
#1 Valuation +50
#2 Profitability +33
#3 Growth +12
#4 Stability +7
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for CVS and ELV Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer CVSELV Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against CVS Health Corporation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
On valuation, Elevance Health, Inc. ranks near the top of the group; CVS Health Corporation sits in the weaker half.
Profitability
On profitability, Elevance Health, Inc. is positioned higher in the group, while CVS Health Corporation is closer to the middle.
Valuation — Dominant Gap
CVS
35
ELV
85
Gap+50in favour of ELV

The multiple-based pricing edge comes from a trailing P/E that is 39 turns lower.

What keeps the gap from being one-sided

Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

The lead is built on both valuation and profitability — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the CVS vs ELV comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-profitability comparisons

Explore how CVS and ELV each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.